Skip to main navigation Skip to search Skip to main content

A cost-utility analysis of several second-line chemoharapy schemes in patients with metastatic breast cancer

  • External organisation

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)533-540
Number of pages6
JournalAnti-Cancer Drugs
Volume12
Issue number6
Publication statusPublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this